Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
Currently, beta-adrenoblockers (β-AB) are regarded as one of the major medication classes in the treatment of patients with chronic heart failure (CHF). In several international studies, β -AB therapy of CHF patients was associated with reduced levels of haemoglobin (Hb) and development of new anaem...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
«SILICEA-POLIGRAF» LLC
2012-04-01
|
| シリーズ: | Кардиоваскулярная терапия и профилактика |
| 主題: | |
| オンライン･アクセス: | https://cardiovascular.elpub.ru/jour/article/view/1776 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|